October 22, 2008 |
A controversial cervical cancer vaccine that has been only recommended for U.S. residents has become a requirement for all new female immigrants ages 11 to 26, sparking an outcry over the order's safety and cost. "It's outrageous," said Sara Sadhwani, project director for the Asian Pacific American Legal Center of Southern California. "It seems absolutely premature to mandate this for immigrant women." The requirement went into effect Aug. 1 and will apply to more than 130,000 immigrants a year.
May 14, 2007 |
When Merck launched a multimillion-dollar marketing campaign last year to promote Gardasil, its new vaccine to prevent cervical cancer, company officials probably did not anticipate that its signature phrase -- "one less" -- would apply not just to malignancies but also to physicians. Yet that slogan has come to symbolize the response of doctors.
December 4, 2008 |
A large study of girls and young women who received the cervical cancer vaccine Gardasil has found only three confirmed cases of allergic reaction out of 380,000 shots. The study, published today in the British Medical Journal, was based on vaccination data from Australia, which has had a nationwide program to vaccinate females ages 12 to 26 in schools since April 2007.
August 11, 2008 |
Sandra Levy wants to do everything she can to safeguard the health of her 11-year-old daughter -- and that, of course, includes cancer prevention. She has had her child inoculated with one shot of Gardasil, the human papilloma virus vaccine that may prevent cervical cancer. But now, she says, she has serious reservations about going ahead with the next two injections of the course. "It's very confusing, and we really don't know if it's 100% safe," says Levy, of Long Beach.
October 10, 2008 |
About a quarter of the nation's teenage girls received the controversial cervical cancer vaccine Gardasil last year in its first full year of distribution, federal authorities said Thursday. "For a new vaccine, 25% is really very good," Lance Rodewald, director of the division of immunization services at the Centers for Disease Control and Prevention, said in a telephone news conference releasing the data.
CALIFORNIA | LOCAL
February 18, 2009 |
The cervical cancer vaccine Gardasil is gaining widespread acceptance in California despite its newness and some controversy over its safety, UCLA researchers have found. One in four teenage girls in the state -- about 378,000 out of 1.5 million -- received at least one dose of the vaccine in 2007, its first full year of distribution, according to the report, released Tuesday by UCLA's Center for Health Policy Research.
August 14, 2006 |
The first outbreak was devastating enough. But within weeks came another outbreak. Then another and another. For Gina Caprio, then 22, the virus that causes genital herpes was nightmarish, "like my life was over." An antiviral drug managed to keep the virus under control, preventing recurrences, but she had to take it every day, year-round.
May 29, 2007
WHEN LOBBYISTS for major drug companies embark on major pushes with politicians, the results are seldom laudable. Though there is reason to hope that a new Merck vaccine, Gardasil, will significantly reduce the incidence of cervical cancer, lawmakers nationwide moved with unseemly haste to require inoculations for all young girls. Their rush seems especially precipitous in light of a new study that has raised questions about how effective the vaccine ultimately will prove.
April 24, 2007 |
Demand for the Gardasil vaccine against cervical cancer is outstripping supply as the state offers the shots for free, but there are no plans to accelerate distribution, a public health official said. "We expected all along there would be an initial demand, but there is a finite amount of resources," said Greg Moore, spokesman for the state Department of Health and Human Services.